Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-81.54M
↓ 106% below average
Average (9y)
$-39.68M
Historical baseline
Range
High:$-23.45M
Low:$-81.54M
CAGR
+11.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-81.54M | -19.1% |
| 2023 | $-68.47M | -57.0% |
| 2022 | $-43.62M | -44.6% |
| 2021 | $-30.17M | +7.2% |
| 2020 | $-32.52M | -22.3% |
| 2019 | $-26.58M | -13.4% |
| 2018 | $-23.45M | +12.8% |
| 2017 | $-26.89M | +19.3% |
| 2016 | $-33.32M | -10.3% |
| 2015 | $-30.21M | - |